14.37
Surgery Partners Inc stock is traded at $14.37, with a volume of 2.09M.
It is down -5.92% in the last 24 hours and down -11.57% over the past month.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.
See More
Previous Close:
$15.03
Open:
$14.84
24h Volume:
2.09M
Relative Volume:
1.34
Market Cap:
$1.88B
Revenue:
$3.34B
Net Income/Loss:
$97.10M
P/E Ratio:
-24.15
EPS:
-0.595
Net Cash Flow:
$208.00M
1W Performance:
-11.35%
1M Performance:
-11.57%
6M Performance:
-9.36%
1Y Performance:
-37.98%
Surgery Partners Inc Stock (SGRY) Company Profile
Name
Surgery Partners Inc
Sector
Industry
Phone
615-234-5900
Address
340 SEVEN SPRINGS WAY, BRENTWOOD, TN
Compare SGRY vs HCA, THC, FMS, EHC, DVA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
SGRY
Surgery Partners Inc
|
14.37 | 1.97B | 3.34B | 97.10M | 208.00M | -0.595 |
|
HCA
Hca Healthcare Inc
|
404.92 | 87.61B | 76.39B | 7.81B | 7.93B | 29.08 |
|
THC
Tenet Healthcare Corp
|
264.56 | 21.57B | 21.46B | 2.65B | 3.35B | 19.23 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.51 | 12.65B | 22.44B | 1.35B | 2.03B | 1.9002 |
|
EHC
Encompass Health Corp
|
121.98 | 12.19B | 6.07B | 793.80M | 464.40M | 5.9914 |
|
DVA
Davita Inc
|
176.70 | 11.49B | 13.84B | 1.10B | 1.49B | 10.42 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-18-25 | Resumed | JP Morgan | Neutral |
| Jul-28-25 | Resumed | BofA Securities | Buy |
| Dec-16-24 | Initiated | BofA Securities | Buy |
| Oct-14-24 | Initiated | UBS | Buy |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-28-24 | Initiated | Macquarie | Outperform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Nov-14-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Jun-02-23 | Upgrade | BofA Securities | Neutral → Buy |
| May-12-23 | Initiated | Mizuho | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-23-22 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-15-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-10-22 | Resumed | Citigroup | Buy |
| Nov-30-21 | Initiated | Barclays | Overweight |
| Nov-29-21 | Upgrade | Stifel | Hold → Buy |
| Nov-01-21 | Initiated | JP Morgan | Neutral |
| Oct-18-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Jun-23-21 | Resumed | Stifel | Hold |
| Sep-17-20 | Reiterated | The Benchmark Company | Buy |
| Apr-27-20 | Upgrade | The Benchmark Company | Hold → Buy |
| Mar-03-20 | Downgrade | The Benchmark Company | Buy → Hold |
| Jan-14-20 | Reiterated | The Benchmark Company | Buy |
| Nov-16-18 | Initiated | UBS | Neutral |
| Sep-18-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jun-28-18 | Upgrade | Stifel | Sell → Hold |
| Jan-30-18 | Reiterated | The Benchmark Company | Buy |
| Nov-01-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Aug-09-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
| Aug-09-17 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Aug-09-17 | Downgrade | Stifel | Hold → Sell |
| Apr-24-17 | Reiterated | Stifel | Hold |
| Mar-10-17 | Downgrade | Stifel | Buy → Hold |
| Jan-31-17 | Initiated | The Benchmark Company | Buy |
| Jun-10-16 | Initiated | KeyBanc Capital Mkts | Overweight |
| Mar-14-16 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-27-15 | Initiated | Stifel | Buy |
| Oct-26-15 | Initiated | RBC Capital Mkts | Outperform |
| Oct-26-15 | Initiated | Raymond James | Strong Buy |
View All
Surgery Partners Inc Stock (SGRY) Latest News
Does Surgery Partners’ (SGRY) Slower M&A Pace Clarify or Complicate Its ASC-Focused Strategy? - simplywall.st
The Top 5 Analyst Questions From Surgery Partners’s Q2 Earnings Call - Yahoo Finance
Surgery Partners (SGRY) Reaffirmed Guidance On Revenue Growth, Is It Still A Bargain? - Sahm
Outpatient & Specialty Care Stocks Q2 Highlights: Surgery Partners (NASDAQ:SGRY) - Yahoo Finance
Surgery Partners Inc. (SGRY) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks
King Street Capital discloses 4.6% Surgery Partners (SGRY) holding in Schedule 13G - Stock Titan
Why (SGRY) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Surgery Partners Inc (1SP.DU) Recent Insider Transactions - Yahoo! Finance Canada
TD Cowen Initiates Surgery Partners(SGRY.US) With Buy Rating, Announces Target Price $19 - Moomoo
Surgery Partners (NASDAQ:SGRY) Downgraded by Zacks Research to Hold - MarketBeat
Surgery Partners (SGRY) Stock Drops As Idaho Falls Sale Reshapes Debt Story - Sahm
Surgery Partners Inc (1SP.DU) insider ownership and holdings - Yahoo Finance UK
Is Surgery Partners Inc (SGRY) a Bargain After 5.8% Drop? GF Val - GuruFocus
Surgery Partners beats Q2 revenue and EPS estimates, with strong growth and positive outlook. - Pluang
SGRY Maintained by TD Cowen -- Price Target Raised to $19.00 - GuruFocus
Cantor Fitzgerald reiterates Surgery Partners stock rating at Overweight By Investing.com - Investing.com Nigeria
SGRY Maintained by RBC Capital -- Price Target Lowered to $19.00 - GuruFocus
Cantor Fitzgerald reiterates Surgery Partners stock rating at Overweight - Investing.com
Benchmark reiterates Buy rating on Surgery Partners stock at $24 By Investing.com - Investing.com South Africa
Benchmark reiterates Buy rating on Surgery Partners stock at $24 - Investing.com
SGRY Reiterated by Cantor Fitzgerald -- Price Target Maintained at $18 - GuruFocus
Surgery Partners (NASDAQ:SGRY) Given Overweight Rating at Cantor Fitzgerald - MarketBeat
Surgery Partners (SGRY) Q2 Earnings: What To Expect - Yahoo Finance
RBC Capital Adjusts Price Target on Surgery Partners to $19 From $20, Keeps Outperform Rating - marketscreener.com
Surgery Partners, Inc. (SGRY) Investor Outlook: Navigating a 16.84% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Surgery Partners Q2 2026 slides show 5% revenue growth, Idaho exit - Investing.com Canada
SGRY Q2 Deep Dive: Portfolio Optimization and Acuity Mix Lead Operating Shift - The Globe and Mail
Surgery Partners, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:SGRY) 2026-08-10 - Seeking Alpha
Why Surgery Partners (NASDAQ:SGRY) Draws Healthcare Attention Monday? - Kalkine Media
Surgery Partners (NASDAQ: SGRY) posts Q2 2026 loss and plans $795M hospital sale - Stock Titan
Surgery Partners Crushes Q2 2026 Profit Estimates by 66.7% - AlphaStreet
Surgery Partners: Q2 Earnings Snapshot - AOL.com
Surgery Partners Releases Q2 2026 Financial Results - AlphaStreet
SGRY Looks 42.7% Undervalued on GF Value™ Despite Profit Challen - GuruFocus
Earnings call transcript: Surgery Partners misses Q2 2026 EPS, revenue beats - Investing.com Nigeria
Surgery Partners Q2 Earnings Call Highlights - MarketBeat
Surgery Partners (NASDAQ:SGRY) Shares Gap Up After Better-Than-Expected Earnings - marketbeat.com
Surgery Partners shares edge lower despite Q2 revenue beat - Yahoo Finance
Surgery Partners Announces Q2 and H1 2026 Financial Results with Investor Call - Kalkine Media
Surgery Partners Inc earnings missed by $0.18, revenue topped estimates - Investing.com Canada
Transcript : Surgery Partners, Inc., Q2 2026 Earnings Call, Aug 10, 2026 - marketscreener.com
Surgery Partners, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Surgery Partners beats revenue but misses on earnings By Investing.com - Investing.com Canada
Surgery Partners (SGRY) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance
Surgery Partners' Q2 Earnings Decline, Revenue Rises - marketscreener.com
Is Surgery Partners Inc (SGRY) a Value Trap? Q2 EPS at -$0.15 on $848.9 Million Revenue; GF Score: 57/100 - GuruFocus
Q2 2026 Surgery Partners Inc Earnings Call Transcript - GuruFocus
SGRY Looks 42.1% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
Surgery Partners beats revenue but misses on earnings - Investing.com
Surgery Partners (NASDAQ:SGRY) Posts Quarterly Earnings Results, Beats Expectations By $0.04 EPS - MarketBeat
Surgery Partners Reports Second Quarter 2026 Results, Reaffirms Full-Year Outlook - Quiver Quantitative
Surgery Partners Inc Stock (SGRY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Surgery Partners Inc Stock (SGRY) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Brittenham Marissa | Chief Strategy Officer |
Mar 13 '26 |
Sale |
12.54 |
3,657 |
45,859 |
94,196 |
| Doherty David T | Chief Financial Officer |
Mar 16 '26 |
Sale |
12.50 |
8,867 |
110,838 |
221,679 |
| Evans Jason Eric | Chief Executive Officer |
Mar 16 '26 |
Sale |
12.47 |
20,400 |
254,388 |
920,386 |
| Baldock Jennifer | Chief Admin & Dev Officer |
Mar 12 '26 |
Sale |
13.17 |
5,798 |
76,360 |
326,474 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):